Inhibrx Biosciences Inc Sustainability Reports
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing advanced biologic therapeutic candidates for oncology and rare diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300VBKG2LTV1TLY22
FIGI: BBG01MS5QB96
1 reports from 2022 to 2022
